Pathstone Holdings’s Bioventus BVS Stock Holding History

Pathstone Holdings’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$199K	Buy	+14,610	New	+$192K	﹤0.01%	2293

Other funds holding BVS

Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return

Pathstone Holdings's BVS Position: Q3 2026 in Review

Pathstone Holdings opened a new position in Bioventus (BVS) in Q3 2026: 14,610 shares worth $199K. The stake represents ﹤0.01% of the portfolio and ranks #2293 among its holdings.

127 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

Pathstone Holdings held 14,610 shares of Bioventus worth $199K as of Q3 2026.
Bioventus was a new Pathstone Holdings position in Q3 2026.
Bioventus made up ﹤0.01% of Pathstone Holdings's portfolio in Q3 2026, its #2293 holding.
127 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.